Skip to NavigationSkip to content

Novo Nordisk opens first Pharmatech branch office in Singapore

Published on 22/10/19 at 11:46am

Novo Nordisk has celebrated the launch of a new Pharmatech A/S branch office based in Singapore at a grand opening event attended by stakeholders, staff and the company’s customers.

The new site, located in the East building of the 37-storey, 150 metre skyscraper complex known as The Gateway at 152 Beach Road, is the first branch office Novo Nordisk Pharmatech, a subsidiary of its global parent focused on the supply of pharmaceutical and biopharmaceutical ingredients, including recombinant insulin and quaternary ammonium compounds.

Rasmus Hother le Fevre, Managing Director and Corporate Vice President of Novo Nordisk Pharmatech A/S, was present at the event on 15 October, where he commented:

“We are thrilled to be expanding our footprint into Asia. This new office will serve as a hub to expand our business in Asia and it is in close proximity to some of the world’s leading biopharmaceutical companies. The location will give us access to a very large pool of the biopharmaceutical development in the region which is a key focus of the company.

“Our new Singapore location extends Novo Nordisk Pharmatech’s heritage of delivering high quality quaternary ammonium compounds as well as recombinant insulin for cell culture media to the pharmaceutical and biopharmaceutical industry.”

He continued: “A local Singapore branch office was a logical step in our business growth strategy and presents a unique opportunity for Novo Nordisk Pharmatech to strengthen our presence. We have been active in this thriving market for several years. The local office in Singapore will allow us to serve both local companies in Singapore as well the rest of the Asian markets much more efficiently.”

Matt Fellows

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches